The mouse KLF1 Nan variant impairs nuclear condensation and erythroid maturation

PLoS One. 2019 Mar 28;14(3):e0208659. doi: 10.1371/journal.pone.0208659. eCollection 2019.

Abstract

Krüppel-like factor 1 (KLF1) is an essential transcription factor for erythroid development, as demonstrated by Klf1 knockout mice which die around E14 due to severe anemia. In humans, >140 KLF1 variants, causing different erythroid phenotypes, have been described. The KLF1 Nan variant, a single amino acid substitution (p.E339D) in the DNA binding domain, causes hemolytic anemia and is dominant over wildtype KLF1. Here we describe the effects of the KLF1 Nan variant during fetal development. We show that Nan embryos have defects in erythroid maturation. RNA-sequencing of the KLF1 Nan fetal liver cells revealed that Exportin 7 (Xpo7) was among the 782 deregulated genes. This nuclear exportin is implicated in terminal erythroid differentiation; in particular it is involved in nuclear condensation. Indeed, KLF1 Nan fetal liver cells had larger nuclei and reduced chromatin condensation. Knockdown of XPO7 in wildtype erythroid cells caused a similar phenotype. We propose that reduced expression of XPO7 is partially responsible for the erythroid defects observed in KLF1 Nan erythroid cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution
  • Anemia, Hemolytic / genetics*
  • Animals
  • Cell Differentiation
  • Cells, Cultured
  • Chromatin / metabolism
  • Disease Models, Animal
  • Embryo, Nonmammalian / metabolism
  • Erythroid Cells / cytology*
  • Erythroid Cells / metabolism
  • Erythropoiesis
  • Female
  • Gene Expression Regulation, Developmental
  • Kruppel-Like Transcription Factors / genetics*
  • Male
  • Mice
  • Sequence Analysis, RNA / methods
  • ran GTP-Binding Protein / genetics*
  • ran GTP-Binding Protein / metabolism

Substances

  • Chromatin
  • Kruppel-Like Transcription Factors
  • RanGTP-binding protein 16
  • erythroid Kruppel-like factor
  • ran GTP-Binding Protein

Grants and funding

TvD and HvdW were supported by the Netherlands Genomics Initiative (NGI Zenith 93511036); IC, TvD, FG and SP by the Landsteiner Foundation for Blood Transfusion Research (LSBR 1040); SH, MvL and SP by the Netherlands Organization for Health Research and Development (ZonMw TOP 40-00812-98-12128); IC, TvD, FG and SP by the EU fp7 Specific Cooperation Research Project THALAMOSS (306201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.